COVID-19 test kit

IgAIgGIgM

Anti-SARS-CoV QuantiVac ELISA (IgG) • - Quantitative ELISA for the determination of the concentration of IgG antibodies against the S1 antigen (including RBD) of SARS-CoV-2 in a broad linear range (using a 6-point calibration curve) • - Excellent correlation with the WHO reference material “First WHO International Standard for anti-SARS-CoV-2 immunoglobulin” (NIBSC code: 20/136) – enables issuing of results in standardised units • - Very good agreement of results in comparison with different neutralisation tests • - Validated for serum, plasma and dried capillary blood as sample material • - Fully automatable Anti-SARS-CoV-2 ELISA (IgG or IgA) • - Detection of anti-SARS-CoV-2 IgG or IgA antibodies using spike protein domain S1 • - Antigen includes the receptor binding domain, which is the main target of neutralising antibodies • - Validated for serum, plasma and dried capillary blood (IgG only) as sample material • - Fully automatable Anti-SARS-CoV-2 NCP ELISA (IgG or IgM) • - Detection of anti-SARS-CoV-2 IgG or IgM antibodies using modified nucleocapsid protein containing only diagnostically relevant epitopes • - Antigen with the strongest immune dominance in the coronavirus family • - Validated for serum, plasma and dried capillary blood (IgG only) as sample material • - Fully automatable